Maarten Timmers
Johnson & Johnson (United States)(US)Janssen (Belgium)(BE)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Tryptophan and brain disorders, Parkinson's Disease Mechanisms and Treatments, Cholinesterase and Neurodegenerative Diseases
Most-Cited Works
- → The β-Secretase BACE1 in Alzheimer’s Disease(2020)632 cited
- → Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study(2018)110 cited
- → Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis(2015)103 cited
- → Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study(2020)100 cited
- → Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials(2011)89 cited
- → The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers(2010)88 cited